BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9628067)

  • 1. [Preoperative treatment with interleukin-2 in colorectal carcinoma].
    Vecchio R; Latteri F; Di Martino M; Lanteri E; Cacciola E
    G Chir; 1998 Apr; 19(4):171-4. PubMed ID: 9628067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy in radical surgery of colorectal carcinoma].
    Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
    Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of preoperative transcatheter arterial chemoembolism on immunity after hepatectomy in patients with liver cancer].
    Su XK; Zhang CQ; Guo RP; Chen MS; Ling XJ; Shi M; Zheng Y; Li JQ
    Ai Zheng; 2002 Sep; 21(9):994-7. PubMed ID: 12508549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
    Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
    Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
    Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
    Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
    Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
    Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
    Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
    J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients.
    Caglayan K; Oner I; Gunerhan Y; Ata P; Koksal N; Ozkara S
    Am J Surg; 2012 Oct; 204(4):416-21. PubMed ID: 23010614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients.
    Brivio F; Lissoni P; Tisi E; Erba L; Barni S; Tancini G; Rescaldani R; Alderi G; Nociti V
    Oncology; 1992; 49(3):215-8. PubMed ID: 1495748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
    Weihrauch MR; Ansén S; Jurkiewicz E; Geisen C; Xia Z; Anderson KS; Gracien E; Schmidt M; Wittig B; Diehl V; Wolf J; Bohlen H; Nadler LM
    Clin Cancer Res; 2005 Aug; 11(16):5993-6001. PubMed ID: 16115944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets].
    Wang JY; Dai SQ; Ye WF; Long H; Lin P; Li BJ; Rong TH
    Ai Zheng; 2005 Jul; 24(7):861-4. PubMed ID: 16004816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of tests recommended by the CDC for the determination of CD4+ T lymphocytes in patients infected by the human immunodeficiency virus].
    Elbim C; Gastal C; Gougerot-Pocidalo MA
    Pathol Biol (Paris); 1994 Nov; 42(9):830-5. PubMed ID: 7753591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.